Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation
- 9 March 2021
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (10)
- https://doi.org/10.1073/pnas.2013374118
Abstract
The recently elucidated proresolving conjugates in tissue regeneration (CTR) maresin-CTR (MCTR), protectin-CTR (PCTR), and resolvin-CTR (RCTR), termed cysteinyl-specialized proresolving mediators (cys-SPMs) each promotes regeneration, controls infection, and accelerates resolution of inflammation. Here, we sought evidence for cys-SPM activation of primordial pathways in planaria (Dugesia japonica) regeneration that might link resolution of inflammation and regeneration. On surgical resection, planaria regeneration was enhanced with MCTR3, PCTR3, or RCTR3 (10 nM), each used for RNA sequencing. The three cys-SPMs shared up-regulation of 175 known transcripts with fold-change > 1.25 and combined false discovery rate (FDR) < 0.002, and 199 canonical pathways (FDR < 0.25), including NF-κB pathways and an ortholog of human TRAF3 (TNFR-associated factor 3). Three separate pathway analyses converged on TRAF3 up-regulation by cys-SPMs. With human macrophages, three cys-SPMs each dose-dependently increased TRAF3 expression in a cAMP-PKA–dependent manner. TRAF3 overexpression in macrophages enhanced Interleukin-10 (IL-10) and phagocytosis of Escherichia coli. IL-10 also increased phagocytosis in a dose-dependent manner. Silencing of mouse TRAF3 in vivo significantly reduced IL-10 and macrophage phagocytosis. TRAF3 silencing in vivo also relieved cys-SPMs’ actions in limiting polymorphonuclear neutrophil in E. coli exudates. These results identify cys-SPM–regulated pathways in planaria regeneration, uncovering a role for TRAF3/IL-10 in regulating mammalian phagocyte functions in resolution. Cys-SPM activation of TRAF3 signaling is a molecular component of both regeneration and resolution of infectious inflammation.Funding Information
- HHS | NIH | National Institute of General Medical Sciences (P01GM095467)
- HHS | NIH | National Institute of General Medical Sciences (R01GM038765)
This publication has 76 references indexed in Scilit:
- OTUD5 Regulates p53 Stability by Deubiquitinating p53PLOS ONE, 2013
- Golgi Disruption and Early Embryonic Lethality in Mice Lacking USO1PLOS ONE, 2012
- Infection regulates pro-resolving mediators that lower antibiotic requirementsNature, 2012
- ABC Transporters B1, C1 and G2 Differentially Regulate Neuroregeneration in MicePLOS ONE, 2012
- Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid FieldOnline Journal of Public Health Informatics, 2012
- Cistrome: an integrative platform for transcriptional regulation studiesGenome Biology, 2011
- MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuitsThe FASEB Journal, 2010
- Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMPBlood, 2008
- Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6Nature, 2005
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005